Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of Fluad-H5N1 with seasonal influenza vaccine in adults
2014-004515-37Phase 2
- Sponsor
- Novartis
- Start
- Oct 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Audenz and influenza vaccine in influenza (3 arms), sponsored by Novartis. Primary endpoint: Number of subjects who responded to two or three vaccinations of the Fluad-H5N1 influenza vaccine.
02
Drugs
Audenzinfluenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2014-004515-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004515-37.